Literature DB >> 22543456

Anti-NGF painkillers back on track?

David Holmes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22543456     DOI： 10.1038/nrd3732

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  18 in total

1.  Drug developers reboot anti-NGF pain programmes.

Authors:  Asher Mullard
Journal:  Nat Rev Drug Discov       Date:  2015-05       Impact factor: 84.694

2.  Immunosympathectomy as the first phenotypic knockout with antibodies.

Authors:  Antonino Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-20       Impact factor: 11.205

Review 3.  Bone cancer pain: from mechanism to therapy.

Authors:  Patrick W Mantyh
Journal:  Curr Opin Support Palliat Care       Date:  2014-06       Impact factor: 2.302

4.  Two compartment pharmacokinetic model describes the intra-articular delivery and retention of rhprg4 following ACL transection in the Yucatan mini pig.

Authors:  Mark Hurtig; Iman Zaghoul; Heather Sheardown; Tannin A Schmidt; Lina Liu; Ling Zhang; Khaled A Elsaid; Gregory D Jay
Journal:  J Orthop Res       Date:  2018-12-17       Impact factor: 3.494

5.  Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration.

Authors:  E Losina; G Michl; J E Collins; D J Hunter; J M Jordan; E Yelin; A D Paltiel; J N Katz
Journal:  Osteoarthritis Cartilage       Date:  2015-12-31       Impact factor: 6.576

Review 6.  Neurotrophins as regulators of urinary bladder function.

Authors:  Peter Ochodnicky; Célia D Cruz; Naoki Yoshimura; Francisco Cruz
Journal:  Nat Rev Urol       Date:  2012-10-09       Impact factor: 14.432

Review 7.  Clinical targeting of the TNF and TNFR superfamilies.

Authors:  Michael Croft; Chris A Benedict; Carl F Ware
Journal:  Nat Rev Drug Discov       Date:  2013-01-21       Impact factor: 84.694

8.  Targeting nerve growth factor (NGF) for pain management: what does the future hold for NGF antagonists?

Authors:  Bernard Bannwarth; Marie Kostine
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

9.  Transcriptional regulator PRDM12 is essential for human pain perception.

Authors:  Ya-Chun Chen; Michaela Auer-Grumbach; Shinya Matsukawa; Manuela Zitzelsberger; Andreas C Themistocleous; Tim M Strom; Chrysanthi Samara; Adrian W Moore; Lily Ting-Yin Cho; Gareth T Young; Caecilia Weiss; Maria Schabhüttl; Rolf Stucka; Annina B Schmid; Yesim Parman; Luitgard Graul-Neumann; Wolfram Heinritz; Eberhard Passarge; Rosemarie M Watson; Jens Michael Hertz; Ute Moog; Manuela Baumgartner; Enza Maria Valente; Diego Pereira; Carlos M Restrepo; Istvan Katona; Marina Dusl; Claudia Stendel; Thomas Wieland; Fay Stafford; Frank Reimann; Katja von Au; Christian Finke; Patrick J Willems; Michael S Nahorski; Samiha S Shaikh; Ofélia P Carvalho; Adeline K Nicholas; Gulshan Karbani; Maeve A McAleer; Maria Roberta Cilio; John C McHugh; Sinead M Murphy; Alan D Irvine; Uffe Birk Jensen; Reinhard Windhager; Joachim Weis; Carsten Bergmann; Bernd Rautenstrauss; Jonathan Baets; Peter De Jonghe; Mary M Reilly; Regina Kropatsch; Ingo Kurth; Roman Chrast; Tatsuo Michiue; David L H Bennett; C Geoffrey Woods; Jan Senderek
Journal:  Nat Genet       Date:  2015-05-25       Impact factor: 38.330

10.  A novel disorder reveals clathrin heavy chain-22 is essential for human pain and touch development.

Authors:  Michael S Nahorski; Lihadh Al-Gazali; Jozef Hertecant; David J Owen; Georg H H Borner; Ya-Chun Chen; Caroline L Benn; Ofélia P Carvalho; Samiha S Shaikh; Anne Phelan; Margaret S Robinson; Stephen J Royle; C Geoffrey Woods
Journal:  Brain       Date:  2015-06-11       Impact factor: 13.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.